Increasing interest in real-world evidence (RWE) across all stakeholder groups has the industry buzzing about its current role in clinical trials and the potential impact of expanded use.

A new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional trials. While the buzz surrounding real world evidence (RWE) may make it ...

The workshops are intended to advance discussions and common knowledge among key stakeholders about complex issues relating to the generation and use of real-world evidence (RWE). The second workshop ...

Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] ...

Hirsch also previously led SignalPath, a local clinical trial technology startup acquired by Verily in 2021. Acquiring Target RWE is an important step in Highlander's efforts to solve challenges ...